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Solution Structure of the Calponin CH
Domain and Fitting to the 3D-Helical
Reconstruction of F-Actin:Calponin
tropomyosin, caldesmon, and calponin. Basic calponin,
one of three genetic variants found almost exclusively in
smooth muscle, was first isolated from chicken gizzard
smooth muscle as a 34 kDa protein that binds to filamen-
tous actin (F-actin) [1]. It has been proposed that cal-
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domains: one at the N terminus, the calponin homologyScotland
(CH) domain, and three repeating domains comprising
the C terminus, the calponin-like repeats (CLR). The CH
domain has approximately 100 residues and was firstSummary
identified in calponin from which its name is derived
[10]. Tandem pairs of CH domains are found in a numberCalponin is involved in the regulation of contractility and
of actin binding proteins such as -actinin, dystrophin,organization of the actin cytoskeleton in smooth muscle
filamin, fimbrin and spectrin (reviewed by Stradal et al.,cells. It is the archetypal member of the calponin homol-
1998 [11]). In these proteins, a role for the CH domain inogy (CH) domain family of actin binding proteins that
actin binding has been demonstrated: two CH domainsincludes cytoskeletal linkers such as -actinin, spectrin,
positioned in tandem within a molecule are required toand dystrophin, and regulatory proteins including VAV,
form a high-affinity actin binding domain (ABD), thusIQGAP, and calponin. We have determined the first
potentially providing multiple sites for interaction withstructure of a CH domain from a single CH domain-
actin. The single CH domain of calponin is not part ofcontaining protein, that of calponin, and have fitted
an ABD and its precise role in actin binding has yet tothe NMR-derived coordinates to the 3D-helical recon-
be determined [12]. Similarly, single copies of the CHstruction of the F-actin:calponin complex using cryo-
domain are found in other cytoskeletal and signalingelectron microscopy. The tertiary fold of this single
proteins where its function is unclear, including the Sac-CH domain is typical of, yet significantly different from,
charomyces cerevisiae homolog Scp1, the smooth mus-those of the CH domains that occur in tandem pairs
to form high-affinity ABDs in other proteins. We thus cle protein SM22, the proto-oncogene Vav, and IQGAP
provide a structural insight into the mode of interaction (reviewed by Stradal et al., 1998 [11]).
between F-actin and CH domain-containing proteins. A number of in vitro studies have defined regions
within the calponin molecule involved in its interactions
Introduction with other proteins. One binding site for actin has been
located between the CH domain and the first CLR in the
The thin filaments of smooth muscle cells comprise actin C-terminal portion, in the region that is also required for
filaments complexed with three other major proteins:
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Figure 1. Analysis of the NOE and CSI Data for the Calponin CH Domain
(A) Number of unambiguous NOE-derived distance restraints used in the structure calculations. Black, gray, and white bars correspond to
sequential (i → i  1), medium range (i → i  (2, 3, or 4)), and long range (i → i  (4)) NOEs, respectively.
(B) NOEs between sequential backbone amide protons (Hn) and between Hn and H (the heights of the bars are proportional to the NOE
intensity).
(C) Consensus CSI derived from the chemical shifts of C, C, CO, and H.
(D) Cartoon representation of the secondary structure elements of the calponin CH domain.
inhibition of the actomyosin ATPase (the so-called actin tion structure of any CH domain. The structure is com-
pared to those of the crystal structures of the actinbinding site 1, ABS1) [13]. A second actin binding site
(ABS2) lies within the region spanning the three C-ter- binding CH domains and the implications for the ob-
served differential actin binding properties are dis-minal CLRs [14, 15]. Two binding sites for Ca2 binding
proteins, such as calmodulin and S100, have been iden- cussed. The structure has also been fitted to the cryo-
EM reconstruction of F-actin decorated with calponin;tified: one within an N-terminal region encompassing
residues 7–45 and the second in the region between a comparison with the F-actin:CH domain reconstruc-
tions of other CH domains is discussed.residues 52 and 144; residues 142–227 contain a tropo-
myosin binding site [16]. Additionally, phosphorylation
sites have been identified on all three CLRs [17]. The Results and Discussion
relative significance of these reported in vitro interac-
tions of calponin in vivo and of its distribution in smooth Structure Determination
A 1 mM sample of 15N,13C-labeled CH domain (residuesmuscle has yet to be ascertained. Calponin may function
separately both as a regulator of smooth muscle con- 27–134) yielded high-quality NMR spectra such that,
using a combination of complementary triple-resonancetraction and as a structural protein in smooth muscle.
The distribution of the sites of interaction throughout experiments, nearly all of the 1H, 15N, and 13C nuclei in
the protein could be unambiguously assigned [22]. Thethis modular molecule implies that the individual do-
mains may have separate functions in vivo. chemical shifts of all the assigned 1H, 13C, 13C, and
13CO provided a consensus Chemical Shift Index (CSI)The crystal structures of several CH domains from
ABDs comprising tandem pairs of CH domains have that is consistent with a predominantly helical structure
(Figure 1C). Five  helices were predicted with no evi-been reported [18–21]. In this report we describe the
three-dimensional solution structure of the archetypal dence of  strands, concordant with the previously re-
ported crystal structures of CH domains. Initial struc-CH domain from chicken gizzard calponin, determined
by multinuclear NMR spectroscopy. This is the first tures were calculated using 3347 distance restraints
derived from the integrated crosspeaks in the 13C-editedstructural investigation of a CH domain from a protein
containing only a single CH domain and is the first solu- NOESY-HSQC spectrum and the 15N-resolved cross-
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Table 1. Structural Statistics of the Final Ensemble of Twenty Refined Structures of the CH Domain of Chicken Calponin
Ensemble Closest to Mean
Number of NOE restraints used:
Intraresidue (i → i) 1034 1034
Sequential (i → i  1) 320 320
Medium range (i → i  (2 to 4)) 234 234
Long range (i → i  (4)) 315 315
Ambiguous 672 672
Total 2575 2575
Average NOE restraint violation (A˚) 0.031  0.007a 0.033
Lennard-Jones energy (kJmol1)b 207  49 222
Coordinate rmsd (A˚):
All residues* (backbone heavy atoms) 0.580 0.493
(all heavy atoms) 0.990 0.873
Residues in helices† (backbone heavy atoms) 0.448 0.381
(all heavy atoms) 0.828 0.708
Parameter rmsd from idealized geometry:
Bond lengths (A˚) 0.0018  6  104c 0.0019
Angles (	) 0.331  0.007c 0.329
Improper dihedrals (	) 0.233  0.076c 0.232
Ramachandran assessment (%)d:
Most favored region 84.5 87.2
Additionally allowed region 9.1 6.4
Generously allowed region 5.1 6.4
Disallowed region 1.3 0.0
a The sum of the NOE violations divided by the total number of restraints, averaged over the ensemble.
b The Lennard-Jones potential was not used at any stage in the refinement.
c The rmsd for each structure, averaged over the ensemble.
d Based upon location of all residues except glycines and prolines (using PROCHECK[46]).
* Residues 33–132
† Helices: residues 33–41, 58–68, 81–97, 116–132
peaks in the 13C,15N HSQC-NOESY-CH3NH spectrum dered terminal residues, is shown in Figure 3A. This
ensemble satisfies the experimentally derived distance[23]. After iteratively filtering the ambiguously assigned
restraints against the calculated structures and removal restraints with, on average, less than one NOE violation
greater than 0.4 A˚ per structure. The Ramachandranof the duplicate restraints, a total of 2575 distance re-
straints were used as the input data for the structure analysis of the main chain torsion angles (φ, 
) of this
ensemble revealed that 84.5% of residues lie within thecalculations (Table 1).
The structure of the expressed protein in solution is most favored region (see Table 1).
well defined by the experimental data except for the four
N-terminal residues (M27–T30) and the two C-terminal Calponin CH Domain Structure
The tertiary fold of the CH domain of calponin is compactresidues (T133 and K134) that are disordered. The reso-
nances arising from the backbone amide protons of and globular (Figure 3B); it is based upon a core of four
main  helices (I, III, IV, and VI) connected by long loops,residues M27, Q29, and T30 (residue 28 is a proline) are
absent from the NMR spectra implying that, at pH 7.0, with two short helical structures (II and V). Three of the
core helices (III, IV, and VI) form a triple-helix bundle inthese protons are in rapid exchange with the bulk water.
This fact, together with the low number of interresidue which helices III and VI are approximately parallel with
helix IV lying at an angle of approximately 40	. TheNOEs observed for the N-terminal residues (see Figure
1A), is consistent with flexible, random-coil structure in N-terminal helix I lies perpendicular to helices III and VI
and the two short helices (II and V) are located closethis region. The 15N relaxation and 1H-15N heteronuclear
NOE experiments indicate that the two C-terminal resi- together at the N termini of helices III and VI, respec-
tively. A 310-helical turn is also present in the loop be-dues are also more mobile in solution relative to the rest
of the domain (Figures 2A and 2B). tween helices IV and V. The compact fold of the structure
is maintained by a network of hydrophobic interactions.There is a good correlation between the consensus
CSI, the pattern of sequential and interresidue NOE in- In particular, helices I and IV are tethered at opposite
sides of the domain by extensive hydrophobic interac-teractions characteristic of -helical structure (depicted
in Figure 1), and the resulting secondary structure ele- tions with both helixes III and VI, while the smaller helix
II has a significant number of interactions with helicesments. Four of the  helices predicted by the CSI corre-
spond to helix I (R32–T42), helix IV (N81–G99), helix V III, IV, V, and VI.
Notable observations made in the NMR data can be(E107–E113), and helix VI (H117-T133) in the final struc-
ture. The remaining CSI-predicted  helix corresponds rationalized by inspection of the refined structure. For
example, one H from L60 exhibits an abnormal upfieldto a region spanning, but considerably shorter than, both
helix II (F50–D56) and helix III (V58–Q68) (Figure 1C). chemical shift of 0.19 ppm in the NMR spectra. In the
refined structures residue L60 is located close to F91,The final ensemble of structures, excluding the disor-
Structure
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Figure 2. NMR Relaxation Data for the Cal-
ponin CH Domain
(A) 15N T1 and T2 relaxation times for the back-
bone amides of the calponin CH domain,
shown as triangles and circles, respectively.
(B) 1H-15N heteronuclear NOEs for the back-
bone amides. Error bars were calculated us-
ing the spectral noise.
(C) Rmsd of the C for the ensemble of 20
structures.
within the hydrophobic core, with one H lying above dues) is 0.45 A˚ compared to 0.58 A˚ for the whole domain
(residues 33–132), again consistent with only a slightthe center of the aromatic ring of F91 and therefore
subject to nuclear shielding from the ring current of the lack of precision in the loop regions compared to the
helices (Table 1). Apart from at the termini, the onlyaromatic ring, resulting in the observed upfield shift.
The extended nature of loop structures results in few significantly higher values of the rmsds of the C posi-
tions in the ensemble of structures are in the interhelicalshort-range interresidue NOE interactions irrespective
of the flexibility of the loop. In the calponin CH domain, loop regions immediately before helix II (residues G47–
N49), between helices III and IV (Q73–K74) (Figure 2C).although there are generally fewer interresidue NOEs
arising from the interhelical loop regions than from the These residues generally have few medium and very
few, if any, long-range NOE interactions and are conse-helices, there are sequential NOEs from all the residues
in loops and very few of these residues have no medium quently less well defined by the experimental data. In
the loop region between helices III and IV, the “dip” inor long range NOE interactions (see Figure 1A). Conse-
quently, and perhaps surprisingly, most of the loop re- the NOE values (V75–V79) and relatively higher T1 values
(V79 and Q80) may indicate that the lack of structuralgions in the calponin CH domain are only slightly less
precisely defined by the experimental data than the ap- definition in this region is due to a genuine increased
flexibility compared to the rest of the molecule (Figuresparently well ordered  helices. The 15N relaxation data
and the 1H-15N heteronuclear NOEs for the backbone 2A and 2B). Also, in this region are found the only two
nonterminal residues with no observable backbone am-amide groups show relatively consistent values through-
out the domain, except for the disordered C terminus, ide resonances in the NMR spectra, probably due to
rapid exchange with the bulk water (Q73 and N81).indicating that there is little variability in flexibility
throughout the molecule (on the 1091012 s1 timescale).
The superposition of the backbones of the ensemble of Comparison of CH Domain Structures
The tertiary fold of the calponin CH domain is very similarstructures highlights, in particular, the precise definition
of the triple helical bundle formed by three of the core to those of the CH domains from the ABDs of the actin
binding proteins dystrophin, utrophin, spectrin, and fim-helices (III, IV, and VI). The mean rmsd of the backbone
heavy atoms of the four core helices (a total of 54 resi- brin, previously determined by X-ray crystallography
Solution Structure of the Calponin CH Domain
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Figure 3. Solution Structure of the CH Domain of Chicken Calponin
(A) A stereo plot of the backbone traces of an ensemble of 20 structures (residues 31–133) superimposed on the backbone heavy atoms of
the four major helices.
(B) Cartoon representations of the structure closest to that of the mean of the ensemble, in two orthogonal orientations. The plots were
produced using MOLSCRIPT [51] and Raster3D [52].
[18–21]. Figure 4 shows the sequences of these CH of fimbrin all lack the helical turns that are present within
the loop between helices III and IV in the structures ofdomains aligned on the basis of their secondary struc-
tural elements, highlighting the similarity in the helical all the remaining CH domains. The two fimbrin domains,
CH1.1 and CH2.1, also have significantly longer loopsregions. The four core helices (I, III, IV, and VI) and helix
V are conserved in all the CH domain structures; the between helices I and II, and between helices II and IV,
respectively. Calponin is unique in having a short 310main differences lie out with these helices. The CH1.1
domain of fimbrin is the only other structure with a de- helix between helices IV and V. Helix I is shorter in cal-
ponin than in all the other structures, and the loop be-fined  helix corresponding to helix II in the calponin
domain. Although all the other structures are also helical tween helices I and II is also much shorter. The noncon-
served glycine at the C terminus of helix I in calponin,in this region, the CH2 domains of the spectrin family
(-spectrin, dystrophin, and utrophin) contain a shorter G43, may permit the necessary conformational freedom
in the following loop required to maintain the relative310 helix here while the remaining structures do not sat-
isfy the criteria for canonical helices here, using PRO- positions of helices I and II.
Analysis of the roles of conserved residues within theMOTIF [24]. The CH domain of calponin, the CH1 do-
mains of dystrophin and utrophin, and the CH2.1 domain structures may explain their conservation in CH do-
Structure
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Figure 4. Structure-Based Alignment of the Sequences of all the CH Domains Whose Structures Have Been Determined to Date
The secondary structural elements defined by PROMOTIF [24] are highlighted in yellow ( helix) and cyan (310 helix). Conserved residues are
indicated as fully (green), strongly (‡), and weakly conserved (†). Residues unique to calponin that are otherwise conserved are highlighted
in red. The numbering scheme is that of chicken calponin and the numbered cylinders represent the  helices of the calponin CH domain.
The names and residue numbers are as follows: CAP, chicken calponin (28–134); DYS1, human dystrophin (13–119); UTR1, human utrophin
(31–135); DYS2, human dystrophin (135–243); UTR2, human utrophin (151–258); SPC2, human -spectrin (173–280); FIM1.1, human fimbrin
(121–241); FIM2.1, human fimbrin (268–375).
mains. For instance, the length of helix III is maintained tion of the helices, with no two structures having rmsd
greater than 1 A˚ for the backbone atoms of the helicesby a proline or glycine at the C terminus (P69 in calponin)
and a fully conserved, dipole-compensating aspartate in the pairwise comparison. The data is concordant with
the sequence analysis of all known CH domains which,(D56), capping the N terminus. The negatively charged
side chain of the fully conserved aspartate in the middle in summary, determined that all the proteins containing
a single CH domain are grouped together in one familyof helix V (D110) appears to interact with the backbone
amides of the corresponding i-3 residue (E107), possibly and that there are two other distinguishable families—
the fimbrin family and the spectrin family—both of whichstabilizing the short helix V; alternatively, this conserved
residue may also have a role in protein:protein interac- contain tandem pairs of CH domain comprising an actin
binding domain (ABD) [11]. Proteins in the fimbrin familytions. Such analyses can also be informative when com-
paring the structures of the different CH domains. In each contain two ABDs, i.e., two tandem pairs of CH
domains. The spectrin family proteins, including-spec-particular, the fully conserved tryptophan in helix I (W37)
is in the same location in all the structures and is in the trin, -actinin, dystrophin, and utrophin, contain only
one ABD. Within the same family, the N-terminal CHsame orientation, stacked between residue i 4 in helix
I and a conserved large hydrophobic residue in helix VI, domains in the ABDs are more similar to each other
than, and are significantly different from, the C-terminalin all the structures except the calponin CH domain and
the fimbrin CH1.1 domain. In calponin, the side chains CH domains in the ABDs. The phylogenetic analysis thus
defines five classes of CH domain: the CH domainsof the corresponding stacking residues (A41 and A128)
are smaller, allowing the tryptophan ring to adopt a from proteins containing single copies, including the
calponins; the N-terminal (CH1) domains from the spec-different orientation. In the fimbrin CH1.1 structure, this
residue is also orientated differently and, in this case, trin family; the C-terminal (CH2) domains from the spec-
trin family; the N-terminal (CH1.1 and CH1.2) domainsmakes interdomain contacts to the fimbrin CH2.1 do-
main within the dimer in the crystal structure [19]. from the fimbrin family; and the C-terminal (CH2.1 and
CH2.2) domains from the fimbrin family. A further classSeveral residues are conserved in the sequences of
all the CH domains except calponin (see Figure 4). The of CH domain-containing actin binding proteins has re-
cently been described although to date no structuralmajority of these are in helix VI, including T118 (mostly
K in the other domains), Q121 (I or L in the others), and data is available [25]. In the pairwise statistical analysis
of the structures (Table 2), the lowest rmsds are betweenT123 (L, Y, or F in the others). The substitution of a large
positively charged side chain with a threonine at the CH domains within these classes, indicating the agree-
ment with the sequence analysis. For example, the rmsdsolvent-exposed position 118 (in calponin) might have
a significant effect on any potential protein-protein or between the CH2 domains of -spectrin and dystrophin
is 0.3 A˚. Similarly, CH domains within the same classligand interactions involving this residue. Both Q121 and
T123 are involved in a number of hydrophobic interac- have similar interhelical angles (Table 2). The calponin
CH domain is significantly different to all the other do-tions, similar to the corresponding conserved hydropho-
bic residues in the other domains. The relatively smaller mains, in accord with its classification in a separate
group.side chain of T123 is compensated for by larger side chains
of residues that are close in space, such as F106 and F91.
In helix IV, a strongly conserved, polar residue (N, Q, or Actin Binding
In addition to the phylogenetic classification distinguish-E) is replaced by a glycine, G89, in the calponin domain.
This does not appear to have any effect upon the tertiary ing the CH1 and CH2 domains, the CH1 domains are
functionally different from the CH2 domains. In isolation,structure of the domain but again may have a significant
effect on any potential interactions in this region. only the CH1 domain has the intrinsic ability to bind
F-actin; however, a tandem pair of CH domains is re-
quired for the full actin binding potential of the ABD. InCH Domain Families
Table 2 shows the statistical comparison of the four the dystrophin and -actinin ABDs, the binding sites
proposed for actin are the N-terminal helices of the CH1core helices of all the CH domains whose structures
have been determined to date, illustrating the conserva- and CH2 domains (helix I) and in a region encompassing
Solution Structure of the Calponin CH Domain
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Table 2. Statistical Analysis of the CH Domain Structures, Performed Using the Backbone Atoms of the Four Core Helices of
Each Structure
A. Rmsd Values of the Pairwise Comparison of All the CH Domains
CAP CH DYS CH1 UTR CH1 DYS CH2 UTR CH2 SPC CH2 FIM CH1.1 FIM CH2.1
CAP CH —
DYS CH1 0.79 —
UTR CH1 0.79 0.25 —
DYS CH2 0.72 0.60 0.57 —
UTR CH2 0.76 0.65 0.62 0.19 —
SPC CH2 0.76 0.62 0.58 0.30 0.31 —
FIM CH1.1 0.78 0.75 0.68 0.69 0.74 0.70 —
FIM CH2.1 0.83 0.65 0.70 0.58 0.59 0.67 0.72 —
B. Interhelical Angles Determined Using PROMOTIF [24]
I/III I/VI III/IV III/VI IV/VI
CAP CH 78.5 80.0 40.4 16.0 45.4
DYS CH1 60.2 55.8 25.1 7.9 30.8
UTR CH1 59.5 55.1 28.3 4.4 32.5
DYS CH2 71.2 64.9 34.5 10.3 37.3
UTR CH2 73.6 60.1 34.0 16.4 40.6
SPC CH2 67.9 65.7 39.1 2.8 39.8
FIM CH1.1 74.2 56.1 25.0 18.1 43.0
FIM CH2.1 80.9 69.4 17.0 13.0 29.7
helices V and VI [26–28]. In the isolated CH1 domains utrophin to the 3D-helical image reconstructions derived
from their respective complexes with F-actin [32–34].of dystrophin, utrophin, -actinin, and -spectrin, helix
In the fimbrin-like orientation the short 310 helix of theVI corresponds to a major site of interaction with F-actin
calponin CH domain, helix V, is closest to the F-actin[29]. In the calponin CH domain structure, these regions
axis with helix VI also lying close to the actin interfaceare the most divergent: helix I is shorter than in the other
(Figure 5A), while in the utrophin-like orientation helix Istructures and, as described above, helix VI is the least
is closest to the F-actin axis (Figure 5B). However, itconserved in sequence.
was possible to rotate the calponin CH domain NMRWe have previously shown, using a sedimentation
structure within the plane of the asymmetry of the EMassay, that intact calponin cosediments with F-actin [3].
CH density envelope, hence the fits were not unique. InSimilar in vitro experiments, however, indicated that the
either orientation the calponin CH domain comes intoisolated CH domain of calponin and F-actin do not
close proximity to sequential actin monomers in onecosediment (unpublished data). The lack of conserva-
strand of the actin filament [termed the pointed endtion in helix VI may explain why the isolated CH domain
(1) and the barbed end (1) monomers]. The closestof calponin does not appear to bind strongly to F-actin.
approaches on actin are to the bottom of subdomain 1Two actin binding regions have so far been located
of the pointed end monomer (residue 354) and the sideoutside the limits of the CH domain in calponin, one
of subdomain 2 and top of subdomain 1 of the barbedimmediately C-terminal of the CH domain [13] and a
end monomer (residues 41 and 92). To further constrainsecond in the C-terminal repeat region [14, 15]. Never-
the orientation of the fitted structure, the known bindingtheless, the calponin CH domain is a major determinant
sites for calponin on actin were taken into consideration.for actin binding, serving to locate the calponin molecule
ABS1 (residues 145–163), the principal actin binding siteon the actin filament and adding considerably to the
in calponin, lies immediately C-terminal to the CH do-overall affinity of calponin for actin [30].
main and has been crosslinked to residues 326–355
of actin [30, 35]. Other crosslinking studies have also
Fitting to the 3D-Helical Reconstructions delineated parts of subdomain 1 of actin as the principal
of F-Actin:Calponin site of calponin interaction [15, 36, 37]. Furthermore, the
The difference maps calculated between F-actin and possibility of interactions with subdomains 3 and 4 of
calponin-decorated F-actin revealed a shield-like den- actin is excluded by tropomyosin binding as calponin
sity that was identified, upon a variety of evidence, to displaces smooth muscle tropomyosin from the “off”
comprise the calponin CH domain [31–33], with the other into the “on” position on F-actin [31]. The orientation
regions of calponin being either extended or unstruc- of the C-terminal of the calponin CH domain toward
tured and thus not clearly visible. Fitting the coordinates subdomain 1 of actin would satisfy the distance con-
of the calponin CH domain structure to the EM difference straints imposed by the known binding location of the
map of the CH domain was constrained by the overall calponin ABS1. The utrophin-like fit [34] clearly fulfils
shape of the CH domain derived from the NMR structure. this requirement, whereas, in the fimbrin orientation, the
Figures 5A and 5B show good fits in two orientations C terminus is oriented away from actin [32, 33] (compare
that also locate likely actin-interacting sequences at the Figures 5A and 5B). The orientation of the utrophin CH
surface of the CH domain reconstructed density enve- domain in the 3D-helical image reconstruction [34]
lope interfacing actin. These orientations are consistent places the central helical region of the utrophin CH1
domain ABD extended down from the top of subdomainwith the fitting of the CH domains from fimbrin and
Structure
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Figure 5. Side View of the Calponin CH Do-
main Structure Fitted to the Difference Den-
sity Map Derived from the 3D-Helical Im-
age Reconstructions of Calponin-Decorated
F-Actin
The calponin CH domain, shown as backbone
trace colored as Figure 3, has been fitted into
the difference density (cyan mesh): (A) in the
fimbrin-like orientation [33] and (B) in the
utrophin-like orientation [34]. The pointed
end monomer of actin is shown in green and
the barbed end monomer is in red. Distances
of the closest approaches to the C of labeled
residues (green) in the fitted atomic model of
F-actin [53] are indicated in red (A˚).
1 toward residue 334 of actin (1) (Figure 6B). Actin nus. The family of actin binding proteins that contain
CH domains include the major cytoskeletal proteinsresidue 334 has been implicated in the direct crosslink
with the calponin ABS1 [30]. Furthermore, visualization -actinin, spectrin, dystrophin, and utrophin, all of which
contain pairs of consecutive CH domains, and a numberof the calponin-like repeat region (ABS2) by 3D-helical
image reconstruction of decorated F-actin is consistent of regulatory proteins, including VAV, IQGAP, and cal-
with such an orientation (J.L.H. and M. Gimona, unpub- ponin, which have only one CH domain. Several struc-
lished data). Taken together, these data strongly sug- tures of actin binding domains (ABD) containing pairs
gest that the calponin CH domain adopts the utrophin of CH domains have recently been solved [19–21]; how-
orientation, with the C terminus pointing down (Figure ever, no structures exist from any single CH domain-con-
6A), and potentially describes a common mode of inter- taining protein. The role of the single CH domain in regula-
action for CH domain-containing actin binding proteins, tory proteins such as calponin is still not clear; while
whether containing one or two CH domains. dispensable for actin binding per se, it is nonetheless an
important locator for the protein on the actin filament and
is crucial to the regulatory function of calponin.Biological Implications
Like other CH domains, the structure of the single
calponin CH domain is based upon four core  helicesCalponin is a 34 kDa actin binding protein involved in
connected by long loops. The calponin structure, how-the regulation of contraction and organization of the
ever, is the most divergent of the solved CH domainactin cytoskeleton in smooth muscle cells [38]. Calponin
structures, in two of the core helices in particular, onehas an important modulatory role on muscle contraction
being considerably shorter and the other lacking severalthrough its ability to bind to F-actin and inhibit the cross-
residues that are otherwise conserved in CH domains.bridge cycling rate of myosin; this effect can be regu-
It is these features that put the calponin CH domain inlated by the reversible phosphorylation of calponin [3,
a unique class [11]. Furthermore, both of these helices36]. The N-terminal half of the calponin molecule con-
correspond to proposed sites of interaction with actintains a single domain of approximately 100 residues,
in the ABD-containing proteins and may explain the dif-termed the calponin homology (CH) domain [10], fol-
lowed by three so-called calponin repeats at the C termi- ferent actin binding ability of the isolated calponin CH
Figure 6. Relation of the Oriented Calponin
CH Domain Structure to the Proposed Bind-
ing Site for Calponin (ABS1) and Comparison
with Utrophin-Induced Fit
(A) Distances of the closest approaches of
the fitted calponin CH domain C terminus (A˚;
red labels) to  helix 334–348 of actin pro-
posed to bind ABS1 of calponin (green labels).
(B) Part of the utrophin actin binding domain
comprising CH1 and the interdomain helical
linker (cyan) as modeled in the cryo-EM re-
construction of utrophin with F-actin [34] in
the context of two actin monomers; pointed
end (green), barbed end (red), in one strand
of the filament.
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quality of the final ensemble of 20 refined structures was assesseddomain. Using 3D image reconstruction of calponin-
with PROCHECK [47] and PROMOTIF [24]. The latter was also em-decorated actin filaments, we have also determined the
ployed to compare the structural properties of the different CHorientation and position of the calponin CH domain on
domain structures.
F-actin. Not only does this provide a model from which The consensus Chemical Shift Index (CSI) was calculated, using
to elucidate the molecular basis of calponin inhibition of all the 1H, 13C, 13C, and 13CO shifts assigned from the NMR experi-
ments, in the CSI program obtained from the University of Albertathe acto-myosin ATPase, but also suggests a common
[48]. For the 15N relaxation and heteronuclear NOE experiments, onlymode of interaction between CH domains and F-actin,
the nonoverlapping resonances of the backbone amide groups werewith the calponin CH domain serving to locate the cal-
analyzed. The T1 and T2 relaxation times were calculated by nonlinearponin molecule on the actin filament thus augmenting least squares fitting.
the actin binding affinity of its other actin binding sites.
Electron Microscopy and Helical Reconstruction
Experimental Procedures F-actin filaments decorated with calponin were reconstituted, and
low-dose negative stain transmission electron microscopy was car-
Cloning, Expression, and Purification ried out, as described previously [31]. Three-dimensional-helical
DNA encoding residues 27–134 from chicken gizzard calponin was image reconstruction was carried out by standard methods using
generated by the polymerase chain reaction from the cDNA and the Brandeis helical package [49]. Difference maps showing mass
was inserted into the pET vector pSJW [39, 40]. The recombinant present only in the F-actin:calponin maps were calculated between
F-actin:calponin and F-actin alone as described previously [31].protein was uniformly enriched with 15N and 13C by overexpression
Fitting of the coordinates of the NMR-derived solution structure ofin Escherichia coli and purified to homogeneity as described pre-
calponin to the reconstructed density was carried out using theviously [22].
program O [50].
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